Page d'accueil  |  Aide  |  Effacer
Anglais  |  Français
 Rechercher  |  Catégories  |  Titres A-Z  |  Pays  |  Comparer pays  |  Index  
Etendre sommaire
Document complet
Dérouler chapitre
Préférences

fermer ce livreDrugs Formulary for Health Center - Ethiopia (DACA; 2004; 222 pages)
Afficher le documentACKNOWLEDGEMENTS
Afficher le documentINTRODUCTION
ouvrir ce répertoire et afficher son contenuGENERAL ADVICE TO PRESCRIBERS
ouvrir ce répertoire et afficher son contenu2. CARDIOVASCULAR DRUGS
ouvrir ce répertoire et afficher son contenu3. RESPIRATORY DRUGS
ouvrir ce répertoire et afficher son contenu4. CENTRAL NERVOUS SYSTEM DRUGS
ouvrir ce répertoire et afficher son contenu5. DRUGS USED IN ANESTHESIA
ouvrir ce répertoire et afficher son contenu6. DRUGS USED IN MUSCULOSKELETAL AND JOINT DISEASE
fermer ce répertoire7. ANTI-INFECTIVE
ouvrir ce répertoire et afficher son contenu7.1. Antibacterials
Afficher le document7.2. Antifungals
Afficher le document7.3. Antiviral
ouvrir ce répertoire et afficher son contenu7.4. Antiprotozoals
ouvrir ce répertoire et afficher son contenu7.5. Anthelmintics
ouvrir ce répertoire et afficher son contenu8. DRUGS USED IN ENDOCRINE DISORDERS AND CONTRACEPTIVES.
Afficher le document9. OBSTETRIC AND GYNAECOLOGICAL MEDICATIONS
ouvrir ce répertoire et afficher son contenu10. BLOOD PRODUCTS AND DRUGS AFFECTING THE BLOOD
ouvrir ce répertoire et afficher son contenu11. DRUGS FOR CORRECTING WATER, ELECTROLYTE AND ACID - BASE DISTURBANCES
ouvrir ce répertoire et afficher son contenu12. VITAMINS
ouvrir ce répertoire et afficher son contenu13. ANTIHISTAMINES AND ANTIALLERGICS
ouvrir ce répertoire et afficher son contenu14. OPHTHALMIC AGENTS
ouvrir ce répertoire et afficher son contenu15. EAR, NOSE, AND THROAT PREPARATIONS
ouvrir ce répertoire et afficher son contenu16. DERMATOLOGIC AGENTS
Afficher le document17. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
Afficher le document18. IMMUNOLOGICAL PREPARATIONS
Afficher le document19. MISCELLANEOUS
Afficher le documentAPPENDIXES
Afficher le documentGLOSSARY
Afficher le documentADVERSE DRUG REACTION REPORTING FORM
Afficher le documentBACK COVER
 

7.3. Antiviral

Acyclovir

Tablet, 200mg, 400mg
Powder for injection, 250mg, 500mg in vial

Indications: - viral infections due to herpes simplex virus (types 1 and 2) and varicella-zoster virus (herpes zoster and chickenpox); see also under dose.

Cautions: - renal impairment (dose should be adjusted), rapid or bolus injection should be avoided and adequate hydration maintained; pregnancy and breast-feeding; see also interaction.

Drug interactions: - probenecid, any nephrotoxic drugs.

Side effects: - nausea, vomiting abdominal pain, diarrhea, headache, fatigue, rash urticaria, pruritus, photosensitivity; rarely hepatitis, jaundice, dyspnoea, angioedema, anaphylaxis, neurological reactions (including dizziness, confusion, hallucinations and drowsiness), acute renal failure, decreases in hematological indices; on intravenous infusion, severe local inflammation (sometimes leading to ulceration), fever, and rarely agitation, tremors, psychosis and convulsions.

Dose and Administration:

By mouth,

Herpes simplex, treatment, 200mg (400mg in the immunocompromised or if absorption impaired) 5 times daily, usually for 5 days; CHILD under 2 years, half adult dose, over 2 years, adult dose.

Herpes simplex, prevention of recurrence, 200mg 4 times daily or 400mg twice daily possibly reduced to 200mg 2 or 3 times daily and interrupted every 6-12 months.

Herpes simplex, prophylaxis in the immunocompromised, 200-400mg 4 times daily; CHILD under 2 years, half adult dose; over 2 years, adult dose

Varicella and herpes zoster, treatment, 800mg 5 times daily for 7 days; CHILD, varicella, 20mg/kg (max. 800mg) 4 times daily for 5 days or under 2 years 200mg 4 times daily, 2-5 years 400mg 4 times daily, over 6 years 800mg 4 times daily.

Intravenous infusion, treatment of herpes simplex in the immunocompromised, severe initial genital herpes, and varicella-zoster, 5mg/kg every 8 hours usually for 5 days, doubled to 10mg/kg every 8 hours usually in varicella-zoster in the immunocompromised and in simplex encephalitis (usually given for 10 days in encephalitis); prophylaxis of herpes simplex in the immunocopromised, 5mg/kg every 8 hours. NEONATE up to 3 months, herpes simplex, 10mg/kg every 8 hours usually for 10 days; CHILD 3 months-12 years, herpes simplex or varicella-zoster in immunocompromised and in simplex encephalitis (usually given for 10 days in encephalitis)

vers la section précédentevers la section suivante

S'il vous plaît envoyez vos commentaires Anglais  |  Français